Injectable Drug Delivery News

  1. CDMO Recro Adds New Filling And Lyophilization Equipment To Meet Industry's Needs 2/24/2022

    Recro Pharma, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today reported key progress in adding fill/finish and lyophilization capabilities to its broad suite of CDMO offerings. All construction and equipment installation related to this service expansion has been completed at the company’s San Diego facility and final validation and commissioning activities are underway.

  2. CDMO PCI Pharma Services Adds 3 Vanrx Sterile Filling Systems To Meet Industry Needs 2/3/2022

    PCI Pharma Services is pleased to announce the addition of three new exceptional automated sterile fill-finish machines in our San Diego and Melbourne facilities. Purchased from Cytiva, this remarkable equipment can pivot between filling different sterile medications into vials and syringes. The addition of these machines comes after our recent acquisition of Lyophilization Services of New England, Inc. (LSNE), specialists in the manufacturing of complex injectables for biologics and small molecules, bringing even broader capabilities to PCI clients across the entire product lifecycle and allowing them to bring their life-changing therapies to market with increased speed and safety.

  3. Global Pharmaceutical Packaging Manufacturer To Invest More Than $70 Million In Kinston Expansion 2/1/2022

    West Pharmaceutical Services, Inc. [NYSE: WST], a global leader in innovative solutions for injectable drug administration, will create approximately 70 jobs in Lenoir County, Governor Roy Cooper announced.

  4. West Announces Landmark Collaboration With Corning In Pharmaceutical Injectable Drug Delivery 1/26/2022

    The exclusive long-term supply and development agreement includes a multimillion-dollar capital and R&D investment in Corning to enable advanced drug containment and delivery system solutions.

  5. Baxter Announces $100 Million Investment In BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility 11/11/2021

    This facility is operated by BioPharma Solutions (BPS), a business unit of Baxter that specializes in partnering with leading pharmaceutical and biotech companies on the development and contract manufacturing of drug product for parenteral (injectable) pharmaceuticals.